« Airlines or drug development | Main | Biotech: transformative or nothing new? »

Bookmark in Connotea

Michael J. Fox wants more

The crowd for the luncheon speaker today proved too big for the Convention Center -- I was in line for the overflow room to hear Michael J. Fox speak and was just three people away from being let in when security stopped us, saying the overflow room was full, too. I limped away, hungry, but Ed Silverman at pharmalot covers the speech on his blog: Fox said, in part, that companies are "more interested in repackaging old ideas for profit" than chasing innovative, riskier drugs, and he added that "Levodopa is the gold-standard treatment for Parkinson's...But it's a little frustrating that the best drug we've got is one that's been around for 40 years. 40 years!"

There's more BIO coverage on pharmalot.com. The blog also is linked to our site along the left-hand side under recommended links.


TrackBack

TrackBack URL for this entry:
http://blogs.nature.com/cgi-bin/mt/mt-tb.cgi/2492

Post a comment

Comments will be reviewed by the blog editors before being published, mainly to ensure that spam and irrelevant material (such as product advertisements) are not published . Please keep your comment brief. Excessively long or offensively phrased entries will be edited.

We strongly encourage you to use your real, full name. E-mail addresses are required in case we need to discuss your comment with you directly. We won't publish your e-mail address unless you request it.

Please enter the numbers you see below - this helps us to avoid spam. If you are having trouble with this system, you can send your comment by e-mail to 'bio2007 at natureny.com'.

please enter code